Literature DB >> 32718406

The need for pulmonary rehabilitation following tuberculosis treatment.

D Visca1, R Centis2, L D'Ambrosio3, M Muñoz-Torrico4, J Muhwa Chakaya5, S Tiberi6, A Spanevello1, G Sotgiu7, G B Migliori2.   

Abstract

Entities:  

Year:  2020        PMID： 32718406     DOI： 10.5588/ijtld.20.0030

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  9 in total

1.  The burden and determinants of post-TB lung disease.

Authors:  S G Mpagama; K S Msaji; O Kaswaga; L J Zurba; P M Mbelele; B W Allwood; B-S Ngungwa; R M Kisonga; M Lesosky; J Rylance; K Mortimer
Journal:  Int J Tuberc Lung Dis       Date:  2021-10-01       Impact factor: 2.373

2.  Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.

Authors:  G B Migliori; F M Marx; N Ambrosino; E Zampogna; H S Schaaf; M M van der Zalm; B Allwood; A L Byrne; K Mortimer; R S Wallis; G J Fox; C C Leung; J M Chakaya; B Seaworth; A Rachow; B J Marais; J Furin; O W Akkerman; F Al Yaquobi; A F S Amaral; S Borisov; J A Caminero; A C C Carvalho; D Chesov; L R Codecasa; R C Teixeira; M P Dalcolmo; S Datta; A-T Dinh-Xuan; R Duarte; C A Evans; J-M García-García; G Günther; G Hoddinott; S Huddart; O Ivanova; R Laniado-Laborín; S Manga; K Manika; A Mariandyshev; F C Q Mello; S G Mpagama; M Muñoz-Torrico; P Nahid; C W M Ong; D J Palmero; A Piubello; E Pontali; D R Silva; R Singla; A Spanevello; S Tiberi; Z F Udwadia; M Vitacca; R Centis; L D Ambrosio; G Sotgiu; C Lange; D Visca
Journal:  Int J Tuberc Lung Dis       Date:  2021-10-01       Impact factor: 3.427

Review 3.  Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs.

Authors:  Emanuele Pontali; Denise Rossato Silva; Florian M Marx; Jose Antonio Caminero; Rosella Centis; Lia D'Ambrosio; Jose Maria Garcia-Garcia; Jeremiah Chakaya Muhwa; Simon Tiberi; Giovanni Battista Migliori
Journal:  Arch Bronconeumol       Date:  2022-06-10       Impact factor: 6.333

4.  Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts.

Authors:  Denise Rossato Silva; Alana Ambos Freitas; Amanda Reis Guimarães; Lia D'Ambrosio; Rosella Centis; Marcela Muñoz-Torrico; Dina Visca; Giovanni Battista Migliori
Journal:  J Bras Pneumol       Date:  2022-05-13       Impact factor: 2.800

5.  Treatment success, but living with the consequences of post-tuberculosis sequelae.

Authors:  C Tadyanemhandu; J Chirenda; C Garvey; J Metcalfe
Journal:  Int J Tuberc Lung Dis       Date:  2020-07-01       Impact factor: 3.427

6.  Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function.

Authors:  B W Allwood; M Stolbrink; N Baines; E Louw; D T Wademan; A Lupton-Smith; S Nel; D Maree; S Mpagama; M Osman; F M Marx; G Hoddinott; M Lesosky; J Rylance; K Mortimer
Journal:  Int J Tuberc Lung Dis       Date:  2021-04-01       Impact factor: 2.373

7.  Clinical and radiographic characteristics of presumptive tuberculosis patients previously treated for tuberculosis in Zambia.

Authors:  Kondwelani Mateyo; Andrew D Kerkhoff; Ian Dunn; Mutinta S Nteeni; Monde Muyoyeta
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

8.  Investigating the response to COVID-19 and understanding severe TB cases: The 2022 Pulmonology TB series.

Authors:  G B Migliori; S Tiberi; R Duarte
Journal:  Pulmonology       Date:  2022-02-08

9.  Tuberculosis and COVID-19 co-infection: description of the global cohort.

Authors: 
Journal:  Eur Respir J       Date:  2022-03-24       Impact factor: 16.671
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.